Pluristem Therapeutics Inc (PSTI)

[Spideyboy]

Great find regarding potential Japanese market size.

If we take this number as correct, about 1 million CLI sufferers in Japan, and Japan's population of 127 million. This would mean about 0.008% of the population.

Now if we assume similar genetics, diet, exercise and China high smoking and thus prevalence in the Chinese population of 1.37 billion people, we're talking almost 11 million sufferers in China. Though not as pronounced as Japan, China does have an aging population issue, so a conservative estimate based on this would set us at I'd say 9 million CLI sufferers.

And thus in following the market for Intermittent Claudication would be even bigger.

Again if the treatment outcome of Phase III CLI is good, China will come back.